And while another study observed that resiniferatoxin pre-treatment reduced pain behaviors in a serum-transfer model of arthritis that closely mimics the disease process of RA, it also found that this desensitization of TRPV1-containing afferents had no effect on the amount of edema and destruction observed in the affected joints [56]. This evidence concerns the gene TRPV1 and arthritic joint disease.